Published in:
01-12-2021 | Acute Respiratory Distress-Syndrome | Research Letter
Extracorporeal membrane oxygenation in non-intubated immunocompromised patients
Authors:
Klaus Stahl, Heiko Schenk, Christian Kühn, Olaf Wiesner, Marius M. Hoeper, Sascha David
Published in:
Critical Care
|
Issue 1/2021
Login to get access
Excerpt
Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) has become an integral part in the rescue therapy of severe acute respiratory distress syndrome (ARDS) and may be lifesaving in patients with refractory hypoxemia [
1]. Ventilator-induced lung injury, ventilator-acquired pneumonia and ventilator-induced diaphragm dysfunction are severe side effects of invasive ventilation and may contribute to the complex pathophysiology of multi-organ failure and death in ARDS [
2]. The use of ECMO in patients who are awake and spontaneously breathing (termed awake ECMO) might avoid side effects and complications associated with sedation, intubation and invasive mechanical ventilation [
3]. Our group reported the first successful use of awake ECMO in six ARDS patients several years ago [
4]. We then concluded that the concept of an awake ECMO strategy as a potential alternative to intubation deserves further evaluation especially in patients with higher mortality following traditional invasive ventilation and ECMO support. …